Stanley Center for Psychiatric Research

The mission of the Stanley Center for Psychiatric Research at Broad Institute is to reduce the burden of serious mental illness through research. Using our ongoing discoveries of genetic variants associated with disease as a launch point, we are contributing to new understandings of pathogenic disease mechanisms, the identification of disease biomarkers, and above all, new treatments.

Stanley Center Scientific Investigators are successfully working on these issues in highly collaborative teams to significantly advance our knowledge of psychiatric disease and the development of treatments. Additionally, the Stanley Center launched the Stanley Global Neuropsychiatric Genetics Initiative (Stanley Global) in 2014, collaborating with research groups around the world to expand genetic sample collection across diverse worldwide populations.

Find out more about our areas of focus:

Through research at the Broad Institute and partnerships with collaborators worldwide, scientists at the Stanley Center aim to develop diagnostics and treatments to help people with mental health conditions. Our research informs our understanding of the biology of psychiatric disorders, neurodevelopmental conditions, and neurodegenerative disorders including schizophrenia, bipolar disorder, autism spectrum disorders, ADHD, and Alzheimer’s.

Click here to read the Stanley Center's Commitment to Genomic Data Sharing